Varian TrueBeam linear accelerator with BrainLAB’s Novalis provides high-energy radiation, which enables treatment with high doses of radiation while minimizing doses to surrounding, normal tissues.
“Caring for cancer patients and their families is complex and requires a comprehensive approach,” said Dr. Rajiv P. Panikkar, chair of the Geisinger Cancer Institute. “This $4.5 million investment improves patients’ experiences and outcomes. Our team can tackle complex cancers in fewer treatments and even deliver repeat radiation in certain situations.”
This cutting-edge combination is the only platform of its kind in northeastern Pennsylvania.
The Truebeam can generate high-quality, 3-D images of the tumor and the surrounding anatomy. Combined with a 6-D robotic couch system, Truebeam adjusts its targets as natural breathing moves the tumor. The TrueBeam can perform stereotactic radiosurgery, considered the most precise method of delivering a high dose of radiation into the body.
“Tumors are treated with pinpoint precision -- no surgery, no incisions and no post-surgical healing. Treatments that once took 10 to 30 minutes can now be completed in less than two minutes,” said Dr. Anand Mahadevan, radiation oncologist and chair of Radiation at Geisinger. “We’re excited to add this cancer-fighting technology to help patients here in northeastern Pennsylvania.”
For more information, call 570-808-7075.
Geisinger is committed to making better health easier for the more than 1.5 million consumers it serves. Founded more than 100 years ago by Abigail Geisinger, the system now includes 13 hospital campuses, a 600,000-member health plan, two research centers and the Geisinger Commonwealth School of Medicine. With 32,000 employees and 1,800 employed physicians, Geisinger boosts its hometown economies in Pennsylvania and New Jersey by billions of dollars annually. For more information, visit www.geisinger.org, or connect with us on Facebook, Instagram, LinkedIn and Twitter.
For media inquiries:
Media Relations Manager